Cline Scientific
Bokslutskommuniké for Cline Scientific AB (publ), 556867-8238, for the period 1 January - 31 December 2022
REG
July - December 2022
- Net sales amounted to 0 (0) SEK.
- Operating profit amounted to 237,140 (-143,519) SEK
- Profit per average number of shares after tax amounted to 0.01 (-0.01)
January - December 2022
- Net sales amounted to 0 (3,991) SEK.
- Operating profit amounted to -2,317,061 (-3,503,694) SEK
- Profit per average number of shares after tax amounted to -0.15 (-0.24)
The report is published at www.clinescientific.com/financial-reports
The company is listed on the Nasdaq First North Growth Market. Redeye AB is Cline Scientific's Certified Adviser. The information was submitted for publication via the contact person listed above, at 8.30am CET on 17 February 2023.
For more information, please contact:
Patrik Sundh, CEO
Email: patrik.sundh@clinescientific.com
Phone: +46 703-585 088
| Datum | 2023-02-17, kl 08:30 |
| Källa | Cision |
100% cashback på aktiecourtage! Handla aktier på eToro och få tillbaka 100% av ditt courtage i 3 månader. Hur? Registrera dig här nu direkt för att ta del av erbjudandet.
Cashback är begränsad till högst $100. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.